Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Questions to ask a patient with nocturia.

Bower WF, Everaert K, Ong TJ, Ervin CF, Norgaard JP, Whishaw M.

Aust J Gen Pract. 2018 Jul;47(7):465-469.

2.

A Danish population-based cohort study of desmopressin use in adults with nocturia or nocturnal enuresis.

Juul KV, Schrøder MK, Mahler B, Rittig S, Nørgaard JP.

Low Urin Tract Symptoms. 2018 Jul 11. doi: 10.1111/luts.12229. [Epub ahead of print]

PMID:
29992760
3.

Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?

Schroeder MK, Juul KV, Mahler B, Nørgaard JP, Rittig S.

Eur J Pediatr. 2018 Mar;177(3):389-394. doi: 10.1007/s00431-017-3074-x. Epub 2017 Dec 19.

PMID:
29260376
4.

An exploratory pilot study with copeptin as a biomarker for individualizing treatment for nocturnal polyuria.

Bruneel E, Goessaert AS, Denys MA, Juul KV, Nørgaard JP, Everaert K.

Low Urin Tract Symptoms. 2017 Oct 23. doi: 10.1111/luts.12192. [Epub ahead of print]

PMID:
29057582
5.

Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.

Juul KV, Malmberg A, van der Meulen E, Walle JV, Nørgaard JP.

BJU Int. 2017 May;119(5):776-784. doi: 10.1111/bju.13718. Epub 2016 Dec 10.

6.

Pitfalls and opportunities in multidisciplinary research about nocturia in adults.

Denys MA, Bruneel E, Van Laecke S, Nørgaard JP, Everaert K.

Acta Clin Belg. 2017 Feb;72(1):2-5. doi: 10.1080/17843286.2016.1177276. Epub 2016 May 10. Review.

PMID:
27164325
7.

Delaying time to first nocturnal void may have beneficial effects on reducing blood glucose levels.

Juul KV, Jessen N, Bliwise DL, van der Meulen E, Nørgaard JP.

Endocrine. 2016 Sep;53(3):722-9. doi: 10.1007/s12020-016-0920-y. Epub 2016 Mar 22.

PMID:
27003433
8.

Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study.

Juul KV, Schroeder MK, Rittig S, Nørgaard JP.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1155-60. doi: 10.1002/pds.3875. Epub 2015 Sep 9.

PMID:
26349846
9.

Delay of first voiding episode is associated with longer reported sleep duration.

Bliwise DL, Holm-Larsen T, Goble S, Juul KV, van der Meulen E, Nørgaard JP.

Sleep Health. 2015 Sep;1(3):211-213. doi: 10.1016/j.sleh.2015.05.001. Epub 2015 Jul 20.

PMID:
29073442
10.

Predictive parameters of response to desmopressin in primary nocturnal enuresis.

Van Herzeele C, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

J Pediatr Urol. 2015 Aug;11(4):200.e1-8. doi: 10.1016/j.jpurol.2015.03.007. Epub 2015 May 21.

PMID:
26059526
11.

Re: A systematic review of the efficacy and safety of desmopressin for nocturia in adults: M. H. Ebell, T. Radke and J. Gardner J Urol 2014;192:829-835.

Nørgaard JP, Juul KV, Gupta J.

J Urol. 2015 May;193(5):1729; discussion 1730. doi: 10.1016/j.juro.2014.11.101. Epub 2015 Feb 3. No abstract available.

PMID:
25660473
12.

Safety profile of desmopressin tablet for enuresis in a prospective study.

Van Herzeele C, De Bruyne P, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

Adv Ther. 2014 Dec;31(12):1306-16. doi: 10.1007/s12325-014-0173-1. Epub 2014 Dec 12.

PMID:
25504157
13.

Short time to first void is associated with lower whole-night sleep quality in nocturia patients.

Bliwise DL, Holm-Larsen T, Goble S, Nørgaard JP.

J Clin Sleep Med. 2015 Jan 15;11(1):53-5. doi: 10.5664/jcsm.4364.

14.

The Nocturia Impact Diary: a self-reported impact measure to complement the voiding diary.

Holm-Larsen T, Andersson F, van der Meulen E, Yankov V, Rosen RC, Nørgaard JP.

Value Health. 2014 Sep;17(6):696-706. doi: 10.1016/j.jval.2014.06.007. Epub 2014 Aug 20.

15.

The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.

Juul KV, Bichet DG, Nielsen S, Nørgaard JP.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40. doi: 10.1152/ajprenal.00604.2013. Epub 2014 Mar 5. Review.

16.

National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.

Juul KV, Schroeder M, Rittig S, Nørgaard JP.

J Clin Endocrinol Metab. 2014 Jun;99(6):2181-7. doi: 10.1210/jc.2013-4411. Epub 2014 Feb 14.

PMID:
24527719
17.

Clinical review: Treatment of neurohypophyseal diabetes insipidus.

Oiso Y, Robertson GL, Nørgaard JP, Juul KV.

J Clin Endocrinol Metab. 2013 Oct;98(10):3958-67. doi: 10.1210/jc.2013-2326. Epub 2013 Jul 24.

PMID:
23884783
19.

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.

Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, Nørgaard JP.

Eur J Pediatr. 2013 Sep;172(9):1235-42. doi: 10.1007/s00431-013-1992-9. Epub 2013 May 16.

20.

Supplemental Content

Loading ...
Support Center